Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults
Status:
Not yet recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of a 16 week treatment with PSIL428 patient reported anxiety
levels in otherwise healthy individuals suffering from depression and or anxiety symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
Wake Network, Inc.
Collaborators:
Professor Roger Gibson Section of Psychiatry Faculty of Medical Sciences UWI The University of The West Indies